54 studies found for:    "Patent ductus arteriosus"
Show Display Options
Rank Status Study
21 Completed Do Elevated BNP Levels Predict Hemodynamically Significant PDAs
Condition: Patent Ductus Arteriosus
Intervention:
22 Completed
Has Results
Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder
Condition: Patent Ductus Arteriosus (PDA)
Interventions: Device: Device closure with AMPLATZER Duct Occluder;   Other: Objective Performance Criteria
23 Withdrawn Second Course of Therapy for Resistant Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Indomethacin;   Drug: Ibuprofen
24 Terminated Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure Rates
Condition: Patent Ductus Arteriosus
Interventions: Drug: optimized ibuprofen;   Drug: Standard Ibuprofen
25 Completed Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDA
Condition: Patent Ductus Arteriosus
Intervention: Drug: ibuprofen l-lysine iv solution (NeoProfen (R) )
26 Completed
Has Results
Pocket Echocardiography System (PES) for Detection of PDA in Neonates
Condition: Patent Ductus Arteriosus
Intervention: Device: PES first, then FFES
27 Completed Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants
Condition: Patent Ductus Arteriosus
Interventions: Other: feeding;   Other: fasting
28 Completed Long Term Results of 450 Percutaneous Closures of PDA in a Single Center
Condition: Patent Ductus Arteriosus
Intervention:
29 Terminated
Has Results
Timing of PDA Closure and Respiratory Outcome in Premature Infants
Condition: Patent Ductus Arteriosus
Interventions: Drug: Early ibuprofen;   Other: Late ibuprofen expectant group (placebo)
30 Completed Ibuprofen and Renal Function in Premature Infants
Conditions: Premature Infants;   Patent Ductus Arteriosus
Intervention: Drug: Ibuprofen
31 Completed Nitric Oxide, Endothelin-1, and the Patency of Ductus Arteriosus in Preterm Infants
Condition: Patent Ductus Arteriosus
Intervention:
32 Completed Efficacy and Safety of Oral Versus Intravenous Ibuprofen for PDA Treatment in ELBW Infants
Condition: Patent Ductus Arteriosus
Intervention: Drug: oral ibuprofen
33 Terminated
Has Results
Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants
Conditions: Prematurity;   Respiratory Distress Syndrome;   Patent Ductus Arteriosus
Interventions: Drug: Survanta (beractant);   Drug: Curosurf (poractant)
34 Completed The Pharmacology and Hemodynamics of Dexmedetomidine in Children With Congenital Heart Disease
Conditions: Cardiac Transplant;   Patent Ductus Arteriosus;   Atrial Septal Defect;   Bidirectional Cavopulmonary Anastomosis
Intervention: Drug: Dexmedetomidine
35 Terminated Early Versus Late Use of Ibuprofen for PDA Closure
Conditions: Patent Ductus Arteriosus;   Prematurity
Intervention: Drug: Ibuprofen
36 Not yet recruiting Hyperion™ International Registry Trial
Conditions: Atrial Septal Defects;   Patent Ductus Arteriosus
Intervention: Device: ASD and PDA closure
37 Withdrawn Impact of Maternal-infant Therapeutics on Safety, Mortality, and Disability
Conditions: Gastroesophageal Reflux;   Presumed Sepsis;   Patent Ductus Arteriosus;   Chronic Lung Disease;   Neurodevelopmental Impairment
Intervention:
38 Recruiting No Treatment Versus Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants
Condition: Bronchopulmonary Dysplasia
Interventions: Drug: Oral ibuprofen;   Drug: Normal saline
39 Completed High-dose Ibuprofen for Patent Ductus Arteriosus (PDA) in Preterm Infant
Condition: Ductus Arteriosus, Patent
Intervention: Drug: Ibuprofen
40 Not yet recruiting Nit-Occlud PDA Post-Approval Study
Condition: Patent Ductus Arteriosus (PDA)
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-54) Show next page of results
Indicates status has not been verified in more than two years